Technologies Overview

Overview

Technologies Overview is a topic within the NeuroWiki knowledge base covering aspects of neurodegenerative disease research and mechanisms.

This section covers technologies used in neurodegenerative disease research and treatment, spanning therapeutic interventions, diagnostic methods, and research tools. [@song2023]

Therapeutic Technologies

Gene Therapy

Gene therapy approaches deliver genetic material to modify disease processes. Key technologies include: [@baker2022]

• [AAV Vectors](/technologies/aav-vectors) — Adeno-associated virus vectors for safe, long-term gene delivery
• [CRISPR-Cas9](/technologies/crispr-cas9) — Gene editing to correct mutations or modify gene expression
• [RNA Interference](/technologies/rna-interference) — Silencing disease-causing genes

Gene therapy for neurodegenerative diseases targets monogenic disorders and aims to deliver neuroprotective factors. Clinical trials are underway for Parkinson's, Alzheimer's, and ALS.

Neuromodulation

Neuromodulation uses electrical or chemical stimulation to modify neural activity:

• [Deep Brain Stimulation (DBS)](/treatments/deep-brain-stimulation) — Implanted electrodes for Parkinson's, tremor
• [Transcranial Magnetic Stimulation](/therapeutics/transcranial-magnetic-stimulation) — Non-invasive brain stimulation for cognitive enhancement
• [Optogenetics](/technologies/optogenetics) — Light-based neural control (research stage)
• [DREADDs](/technologies/dreads) — Chemogenetic control of neuronal activity

...

Overview

Technologies Overview is a topic within the NeuroWiki knowledge base covering aspects of neurodegenerative disease research and mechanisms.

This section covers technologies used in neurodegenerative disease research and treatment, spanning therapeutic interventions, diagnostic methods, and research tools. [@song2023]

Therapeutic Technologies

Gene Therapy

Gene therapy approaches deliver genetic material to modify disease processes. Key technologies include: [@baker2022]

• [AAV Vectors](/technologies/aav-vectors) — Adeno-associated virus vectors for safe, long-term gene delivery
• [CRISPR-Cas9](/technologies/crispr-cas9) — Gene editing to correct mutations or modify gene expression
• [RNA Interference](/technologies/rna-interference) — Silencing disease-causing genes

Gene therapy for neurodegenerative diseases targets monogenic disorders and aims to deliver neuroprotective factors. Clinical trials are underway for Parkinson's, Alzheimer's, and ALS.

Neuromodulation

Neuromodulation uses electrical or chemical stimulation to modify neural activity:

• [Deep Brain Stimulation (DBS)](/treatments/deep-brain-stimulation) — Implanted electrodes for Parkinson's, tremor
• [Transcranial Magnetic Stimulation](/therapeutics/transcranial-magnetic-stimulation) — Non-invasive brain stimulation for cognitive enhancement
• [Optogenetics](/technologies/optogenetics) — Light-based neural control (research stage)
• [DREADDs](/technologies/dreads) — Chemogenetic control of neuronal activity

DBS is clinically approved for Parkinson's disease and essential tremor. TMS shows promise for Alzheimer's and depression.

Drug Delivery

Effective CNS drug delivery remains challenging due to the [blood-brain barrier](/entities/blood-brain-barrier):

• [Blood-Brain Barrier Crossing](/technologies/bbb-crossing) — Strategies including Trojan horses, focused ultrasound
• [Nanoparticle Delivery](/technologies/nanoparticle-delivery) — Targeted nanoparticles for drug transport
• [Intranasal Delivery](/technologies/intranasal-delivery) — Non-invasive CNS delivery via nasal passages
• [Convection-Enhanced Delivery](/therapeutics/convection-enhanced-delivery) — Direct infusion into brain tissue

Diagnostic Technologies

Imaging

Neuroimaging provides structural and molecular information:

• [PET Imaging](/technologies/pet-imaging) — Molecular imaging for amyloid, [tau](/proteins/tau), dopamine
• [MRI Technologies](/technologies/mri-technologies) — Structural, functional, and diffusion imaging
• [Optical Imaging](/technologies/optical-imaging) — Fluorescence and two-photon imaging

Biomarker Detection

Sensitive detection enables early diagnosis:

• [Simoa Technology](/technologies/simoa) — Ultra-sensitive immunoassays for p-tau, [NfL](/biomarkers/neurofilament-light-chain-nfl)
• [Seed Amplification Assay](/technologies/seed-amplification) — Detection of misfolded proteins
• [Mass Spectrometry](/technologies/mass-spectrometry) — Proteomics and metabolomics

Research Technologies

Stem Cell Technologies

• [iPSC Disease Models](/technologies/ipsc-disease-models) — Patient-derived [neurons](/entities/neurons) for disease modeling
• [Brain Organoids](/technologies/brain-organoids) — 3D brain tissue cultures

Omics Technologies

• [Single-Cell Genomics](/technologies/single-cell-genomics) — Cell-type specific analysis
• [Spatial Transcriptomics](/technologies/spatial-transcriptomics) — Gene expression with spatial context
• [Proteomics](/technologies/proteomics) — Large-scale protein analysis

Structural Biology

• [Cryo-Electron Microscopy](/technologies/cryo-electron-microscopy) — Atomic resolution protein structures
• [X-ray Crystallography](/technologies/xray-crystallography) — Protein structure determination

Technology Rankings

See [Technology Rankings](/technologies/rankings) for a ranked list by therapeutic potential and development stage.

Technology Integration

Modern neurodegenerative disease research increasingly combines multiple technologies:

Multi-Omics Integration

Combining genomics, transcriptomics, proteomics, and metabolomics provides comprehensive disease understanding. Single-cell approaches reveal cell-type specific changes impossible to detect in bulk tissue.

Imaging and Biomarker Correlation

Linking PET amyloid/tau imaging with CSF and plasma biomarkers enables validation of fluid biomarkers against ground-truth imaging. This accelerates biomarker development and clinical qualification.

Disease Modeling

iPSC-derived neurons from patient samples enable disease modeling with human genetics. Combined with CRISPR editing, isogenic cell lines reveal mutation-specific effects.

Future Directions

The technology landscape continues evolving:

• Spatial Biology: Mapping molecular changes within intact tissue architecture
• Proteomics: Next-gen proteomics identifying thousands of proteins
• Neural Interfaces: High-density electrode arrays for circuit mapping
• AI/ML: Deep learning for image analysis, biomarker discovery, patient stratification

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

Topics

• [Technologies Overview](/technologies/overview) — This page
• [Technologies Rankings](/technologies/rankings) — Ranked list by research activity
• [Technologies Dashboard](/technologies/dashboard) — Data visualizations and metrics

Summary Statistics

• [Total Pages:** 107 Technologies pages in this section](/technologies)
• [Last Updated:** This section is actively maintained](/genes/th)

A-Z All Pages

• [AI-Decoded Neural Intent Brain-Computer Interfaces](/technologies/ai-decoded-neural-intent-bci)
• [ALS Communication Brain-Computer Interfaces](/technologies/als-communication-bci)
• [Acoustoelectric Brain Imaging](/technologies/acoustoelectric-brain-imaging)
• [Adaptive Deep Brain Stimulation (DBS) Technology](/technologies/adaptive-dbs)
• [Allen Brain Atlas API for Neurodegeneration Workflows](/technologies/allen-brain-atlas-api)
• [AllenSDK in Neurodegeneration Research](/technologies/allensdk)
• [AlphaFold for Neurodegenerative Diseases](/technologies/alphafold)
• [Antisense Oligonucleotide Therapy in Neurodegeneration](/technologies/antisense-oligonucleotides)
• [Artificial Intelligence for Neurodegeneration Research](/technologies/artificial-intelligence-neurodegeneration)
• [Artificial Intelligence in Neurodegeneration Research](/technologies/ai-neurodegeneration)
• [BCI Clinical Trials for Neurodegenerative Diseases](/technologies/bci-clinical-trials-neurodegenerative)
• [BCI Clinical Trials for Neurodegenerative Diseases](/technologies/bci-clinical-trials)
• [BCI for Alzheimer's Disease](/technologies/bci-alzheimers-disease)
• [BCI for FTD Behavioral Circuit Modulation](/technologies/bci-ftd-behavioral-modulation)
• [BCI for Multiple Sclerosis](/technologies/bci-multiple-sclerosis)
• [BCI-Assisted Rehabilitation](/technologies/bci-rehabilitation)
• [Biointegrated Neural Interfaces](/technologies/biointegrated-neural-interfaces)
• [Bitbrain Brain-Computer Interface](/technologies/bitbrain)
• [Blackrock Neurotech](/technologies/blackrock-neurotech)
• [Blackrock Neurotech — Brain-Computer Interface](/technologies/blackrock)
• [Brain Knowledge Platform](/technologies/brain-knowledge-platform)
• [Brain Organoid-Silicon Interface Technology](/technologies/brain-organoid-silicon-interface)
• [Brain Organoids](/technologies/brain-organoids)
• [Brain Organoids for Neurodegeneration Research](/technologies/brain-organoids-neurodegeneration)
• [Brain-Computer Interface Technologies](/technologies/bci-index)
• [Brain-Computer Interface Technologies](/technologies/bci)
• [Brain-Computer Interface Technology](/technologies/brain-computer-interface)
• [Brain-Computer Interface Technology Landscape](/technologies/bci-technology-landscape)
• [Brain-Computer Interface for Frontotemporal Dementia](/technologies/bci-frontotemporal-dementia)
• [Brain-Computer Interface for Huntington's Disease](/technologies/bci-huntingtons-disease)

[See all 107 technologies pages...](/technologies/rankings)

Topics

• Technologies Overview — This page
• Technologies Rankings — Ranked list by research activity
• Technologies Dashboard — Data visualizations and metrics

Summary Statistics

• Total Pages: 107 Technologies pages in this section
• Last Updated: This section is actively maintained

A-Z All Pages

• AI-Decoded Neural Intent Brain-Computer Interfaces
• ALS Communication Brain-Computer Interfaces
• Acoustoelectric Brain Imaging
• Adaptive Deep Brain Stimulation (DBS) Technology
• Allen Brain Atlas API for Neurodegeneration Workflows
• AllenSDK in Neurodegeneration Research
• AlphaFold for Neurodegenerative Diseases
• Antisense Oligonucleotide Therapy in Neurodegeneration
• Artificial Intelligence for Neurodegeneration Research
• Artificial Intelligence in Neurodegeneration Research
• BCI Clinical Trials for Neurodegenerative Diseases
• BCI Clinical Trials for Neurodegenerative Diseases
• BCI for Alzheimer's Disease
• BCI for FTD Behavioral Circuit Modulation
• BCI for Multiple Sclerosis
• BCI-Assisted Rehabilitation
• Biointegrated Neural Interfaces
• Bitbrain Brain-Computer Interface
• Blackrock Neurotech
• Blackrock Neurotech — Brain-Computer Interface
• Brain Knowledge Platform
• Brain Organoid-Silicon Interface Technology
• Brain Organoids
• Brain Organoids for Neurodegeneration Research
• Brain-Computer Interface Technologies
• Brain-Computer Interface Technologies
• Brain-Computer Interface Technology
• Brain-Computer Interface Technology Landscape
• Brain-Computer Interface for Frontotemporal Dementia
• Brain-Computer Interface for Huntington's Disease

See all 107 technologies pages...

References

[@song2023]: Song P. AAV gene therapy for neurological disorders. Nature Reviews Drug Discovery. 2023.
[@baker2022]: Baker M. Next-generation CRISPR technologies. Nature Methods. 2022.